112 related articles for article (PubMed ID: 23765629)
1. Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry.
Kasuga K
Methods Mol Biol; 2013; 1023():203-18. PubMed ID: 23765629
[TBL] [Abstract][Full Text] [Related]
2. Contribution of mass spectrometry-based proteomics to immunology.
Hillen N; Stevanovic S
Expert Rev Proteomics; 2006 Dec; 3(6):653-64. PubMed ID: 17181480
[TBL] [Abstract][Full Text] [Related]
3. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
4. MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.
Murphy JP; Konda P; Kowalewski DJ; Schuster H; Clements D; Kim Y; Cohen AM; Sharif T; Nielsen M; Stevanovic S; Lee PW; Gujar S
J Proteome Res; 2017 Apr; 16(4):1806-1816. PubMed ID: 28244318
[TBL] [Abstract][Full Text] [Related]
5. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
Nelde A; Kowalewski DJ; Stevanović S
Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
[TBL] [Abstract][Full Text] [Related]
6. Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
Lemmel C; Weik S; Eberle U; Dengjel J; Kratt T; Becker HD; Rammensee HG; Stevanovic S
Nat Biotechnol; 2004 Apr; 22(4):450-4. PubMed ID: 15004565
[TBL] [Abstract][Full Text] [Related]
7. Improved Prediction of Bovine Leucocyte Antigens (BoLA) Presented Ligands by Use of Mass-Spectrometry-Determined Ligand and in Vitro Binding Data.
Nielsen M; Connelley T; Ternette N
J Proteome Res; 2018 Jan; 17(1):559-567. PubMed ID: 29115832
[TBL] [Abstract][Full Text] [Related]
8. Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines.
Mohan SV; Datta KK; Ziegman R; Smith C; Gowda H
STAR Protoc; 2021 Mar; 2(1):100385. PubMed ID: 33778779
[TBL] [Abstract][Full Text] [Related]
9. Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry.
Artemenko KA; Bergström Lind S; Elfineh L; Mayrhofer C; Zubarev RA; Bergquist J; Pettersson U
Analyst; 2011 May; 136(9):1971-8. PubMed ID: 21403953
[TBL] [Abstract][Full Text] [Related]
10. The use of mass spectrometry to identify antigens from proteasome processing.
Burlet-Schiltz O; Claverol S; Gairin JE; Monsarrat B
Methods Enzymol; 2005; 405():264-300. PubMed ID: 16413318
[TBL] [Abstract][Full Text] [Related]
11. A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays.
Brockman AH; Orlando R; Tarleton RL
Rapid Commun Mass Spectrom; 1999; 13(11):1024-30. PubMed ID: 10368978
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Mass Spectrometry-Based MHC-I Peptide Identification Through a Targeted Database Search Approach.
Konda P; Murphy JP; Nielsen M; Gujar S
Methods Mol Biol; 2019; 2024():301-307. PubMed ID: 31364058
[TBL] [Abstract][Full Text] [Related]
13. A practical guide to structure-based prediction of MHC-binding peptides.
Ranganathan S; Tong JC
Methods Mol Biol; 2007; 409():301-8. PubMed ID: 18450010
[TBL] [Abstract][Full Text] [Related]
14. Improving MHC-I Ligand Identifications from LC-MS/MS Data by Incorporating Allelic Peptide Motifs.
Konda P; Murphy JP; Gujar S
Proteomics; 2019 Mar; 19(5):e1800458. PubMed ID: 30710433
[TBL] [Abstract][Full Text] [Related]
15. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Major Histocompatibility Complex (MHC)-Associated Peptides by Immunoaffinity Purification.
Penny SA; Malaker SA
Methods Mol Biol; 2019; 2024():235-243. PubMed ID: 31364053
[TBL] [Abstract][Full Text] [Related]
17. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
[TBL] [Abstract][Full Text] [Related]
18. Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.
Sturm T; Sautter B; Wörner TP; Stevanović S; Rammensee HG; Planz O; Heck AJR; Aebersold R
J Proteome Res; 2021 Jan; 20(1):289-304. PubMed ID: 33141586
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.
Purcell AW; Ramarathinam SH; Ternette N
Nat Protoc; 2019 Jun; 14(6):1687-1707. PubMed ID: 31092913
[TBL] [Abstract][Full Text] [Related]
20. Exploring the MHC-peptide matrix of central tolerance in the human thymus.
Adamopoulou E; Tenzer S; Hillen N; Klug P; Rota IA; Tietz S; Gebhardt M; Stevanovic S; Schild H; Tolosa E; Melms A; Stoeckle C
Nat Commun; 2013; 4():2039. PubMed ID: 23783831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
